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 An improved synthesis of 2-(1,2,4-thiadiazol-5-yl)pyridine by interception of an intermediate involved in a competing cyclisation reaction 
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For some time we have been interested in the synthesis and study of new chelating N-heterocyclic ligands and their use in coordination and metallosupramolecular chemistry.1 In particular, we have focussed on the use of ligands incorporating less commonly studied heterocyclic ring systems, such as tetrazoles,2 1,2-benzisoxazoles,3 furoxans,4 benzotriazoles,5,6 1,4,2,5-dioxadiazines,7 thiazolo[5,4-d]thiazoles,8 1,2,3-thia(and selena)diazoles,9 pyridazines,10 1,2,5-oxadiazoles and 1,2,5-thiadiazoles.11,12 We have been particularly attracted to sulfur-containing azole ligands as these seem to impart intriguing properties to the resultant metal complexes. 
Within this context, we identified 2-(1,2,4-thiadiazol-5-yl)pyridine (1) (Scheme 1) as a potentially useful chelating ligand and were surprised  to  find  that  the  only  literature 
Scheme 1.  Synthesis of 1 and 3.
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references to this compound relate to two reports of its use as a ligand involved in ruthenium(II) complexes.13,14 Neither of these papers described experimental details of its synthesis, other than a yield (32%), a melting point and an oblique reference to the synthetic method, which cited a two-step synthetic procedure employed by Lin et al.15 This involved a process in which a thioamide was reacted with N,N-dimethylformamide dimethylacetal to form a thioacyl amidine that was subsequently reacted with hydroxylamine-O-sulfonic acid to furnish the thiadiazole product. These authors15 reported the synthesis of the isomeric 3- and 4-substituted pyridines, but not the 2-substituted isomer.
When we attempted to employ this synthetic route we found that reaction of thiopicolinamide with N,N-dimethylformamide dimethylacetal led to a different product to the expected amidine (2). A high-resolution mass spectrometry measurement provided a molecular formula of C10H13N3S for the product and this was supported by elemental analysis. The 1H-NMR spectrum (Figure 1) clearly showed that this product has reduced aromaticity of the pyridine ring, suggesting a 1,2-fused pyrido subunit, and that it possessed dimethylamino and methylthio substituents. Complete 1H- and 13C-NMR assignments of this molecule were made, and by comparison of the NMR data with a similar molecule containing an imidazo[1,5-a]pyridine system,16 we identified the product as 3-(dimethylamino)-1-methylthioimidazo[1,5-a]pyridine (3).17 We believe that formation of this new compound is initiated by intramolecular cyclisation of the pyridyl nitrogen onto the amidine carbon of 2, a process not available to the 3- and 4-pyridyl analogues (Scheme 1). Formation of imidazo[1,5-a]pyridines by related cyclisations are known.18,19 


Figure 1. 1H-NMR spectrum of 3.
We next decided to monitor the progress of this reaction by 1H-NMR. We found that after combining the reactants for 30 minutes, the thiopicolinamide was completely consumed and a single compound was formed, the spectrum of which was consistent with it being the desired amidine (2). However, during the course of the next ninety minutes, this compound underwent further reaction to generate a mixture of compounds containing the rearranged product (3). 
We felt that the course of the reaction could be intercepted by simply carrying out the two steps without isolation of the intermediate, conveniently turning the synthesis into a 'one-pot' procedure. Accordingly, thiopicolinamide and N,N'-dimethylformamide dimethyl acetal were combined and allowed to react for 30 minutes before hydroxylamine-O-sulfonic acid and pyridine in a solvent mixture of methanol/ethanol were added and the resulting mixture allowed to react at room temperature. By this method (1) was obtained in 75% yield after workup and purification,20 a considerable improvement over the previously reported yield of 32%.
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